- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT07764367
Evaluation the Effects of Chewing Gum
11. august 2026 oppdatert av: Pınar AKBAŞ, Karabuk University
Evaluating the Effects of Chewing Gum on Bowel Function, Postpartum Comfort and Satisfaction With Caesarean Birth: A Randomized Controlled Trial
This study was conducted as a randomized controlled trial to evaluate the effects of gum chewing in the early postpartum period on bowel function, postpartum comfort, and postpartum satisfaction in women.
The sample consisted of 66 women, 33 in the experimental group and 33 in the control group.
Data were collected using a pre-assessment form, a demographic information form, a bowel function monitoring form, a postpartum comfort scale, and a maternal satisfaction scale (cesarean delivery).
While the control group received no intervention other than standard postoperative care, the experimental group underwent gum chewing at 4, 6, and 8 hours postpartum.
Studieoversikt
Status
Fullført
Intervensjon / Behandling
Studietype
Intervensjonell
Registrering (Faktiske)
66
Fase
- Ikke aktuelt
Kontakter og plasseringer
Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.
Studiesteder
-
-
-
Karabük, Tyrkia (Türkiye), 78100
- Karabuk Training and Research Hospital
-
-
Deltakelseskriterier
Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
- Voksen
Tar imot friske frivillige
Ja
Beskrivelse
Inclusion Criteria:
- Women aged 18-45 years
- Women who underwent cesarean section under epidural or spinal anesthesia
Exclusion Criteria:
- Cesarean delivery under general anesthesia
- Jaw or oral membrane problems that may prevent chewing gum
- Any systemic or chronic disease
- Any mental or psychiatric illness
- History of chronic constipation
- Any communication problems, including mental, auditory, or visual impairments
Studieplan
Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Støttende omsorg
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: chewing gum group
|
In addition to routine post-cesarean care, women in the experimental group were given commercially available sugar-free, aspartame-free, sorbitol-free, xylitol-free, soft, and easy-to-chew gum to chew from the 4th hour post-operatively until they switched to Diet I. Since oral feeding was started at the 6th hour in the clinic where the study was conducted, women in the experimental group were given gum to chew at the 4th, 6th, and 8th hours after cesarean section, with each chewing session lasting between 15 and 30 minutes.
The women were instructed to chew their gum at the 6th hour post-cesarean and then drink water before starting oral feeding.
The gum used in one period was not repeated in the next period; a new pack of gum was used.
In this way, each woman chewed a total of 3 pieces of gum.
|
|
Ingen inngripen: no initiative
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
Bowel motility (time to pass gas and stool)
Tidsramme: 2 hours after cesarean section (baseline) and 44-48 hours after cesarean section (post-test).
|
2 hours after cesarean section (baseline) and 44-48 hours after cesarean section (post-test).
|
|
|
Maternal Satisfaction With Caesarean Birth Measured Using the Scale for Measuring Maternal Satisfaction-Caesarean Birth
Tidsramme: 2 hours after cesarean section (baseline) and 44-48 hours after cesarean section (post-test).
|
This measurement was evaluated using the Maternal Satisfaction Assessment Scale at Birth (Cesarean Birth).
Developed by Güngör and Beji (2009) to assess the experiences of women in the early postpartum period after cesarean delivery, this scale consists of 42 items on a 5-point Likert scale with 10 sub-dimensions: perception of the healthcare team, preparation for cesarean section, reassurance, participation in decision-making and information sharing, meeting the baby, postpartum care, hospital room, hospital facilities, respect for privacy, and meeting expectations.
Each item on the scale is scored between 1 (strongly disagree) and 5 (strongly agree).
Twelve items (8, 9, 10, 19, 20, 21, 22, 34, 35, 37, 40, 41) are reverse-scored.
The highest possible score is 210, and the lowest is 42.
As the score on the scale increases, the level of satisfaction also increases.
|
2 hours after cesarean section (baseline) and 44-48 hours after cesarean section (post-test).
|
|
Postpartum Comfort Level Measured Using the Postpartum Comfort Scale (PCS)
Tidsramme: 2 hours after cesarean section (baseline) and 44-48 hours after cesarean section (post-test).
|
This measurement was evaluated using the Postpartum Comfort Scale.
It is a scale developed by Karakaplan and Yıldız, based on Kolcaba's general comfort scale, and adapted for our country.
It was developed to evaluate the comfort of women who have had cesarean and vaginal deliveries.
The scale consists of 34 items with 3 sub-dimensions: sociocultural, psychospiritual, and physical, using a 5-point Likert scale.
Each item is scored between 1 (strongly disagree) and 5 (strongly agree).
The highest possible score on the scale is 170, and the lowest is 34.
The Postpartum Comfort Scale and sub-dimension scores are evaluated based on the total score, and as the score increases, the comfort level of the women increases.
|
2 hours after cesarean section (baseline) and 44-48 hours after cesarean section (post-test).
|
Samarbeidspartnere og etterforskere
Det er her du vil finne personer og organisasjoner som er involvert i denne studien.
Sponsor
Studierekorddatoer
Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.
Studer hoveddatoer
Studiestart (Faktiske)
10. desember 2024
Primær fullføring (Faktiske)
30. september 2025
Studiet fullført (Faktiske)
30. september 2025
Datoer for studieregistrering
Først innsendt
2. august 2026
Først innsendt som oppfylte QC-kriteriene
11. august 2026
Først lagt ut (Faktiske)
13. august 2026
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
13. august 2026
Siste oppdatering sendt inn som oppfylte QC-kriteriene
11. august 2026
Sist bekreftet
1. august 2026
Mer informasjon
Begreper knyttet til denne studien
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 2024-KAEK-82
- KBÜBAP-25-YL-030 (Annet stipend/finansieringsnummer: Karabük University Scientific Research Projects Coordination Unit)
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
NEI
Legemiddel- og utstyrsinformasjon, studiedokumenter
Studerer et amerikansk FDA-regulert medikamentprodukt
Nei
Studerer et amerikansk FDA-regulert enhetsprodukt
Nei
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .